Editorial introductions : Current Opinion in Infectious Diseases

Secondary Logo

Journal Logo


Editorial introductions

Editor(s): Slavin, Monica; Yong, Michelle K.; Bassetti, Matteo

Current Opinion in Infectious Diseases: December 2022 - Volume 35 - Issue 6 - p vii-viii
doi: 10.1097/QCO.0000000000000887
  • Free

Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.


Monica Slavin

Monica Slavin

Professor Monica Slavin leads the National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence in Infections in Cancer at Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia. She is Director of the Department of Infectious Diseases at Peter MacCallum Cancer Centre and of the Immunocompromised Host Infection Service at Royal Melbourne Hospital in Melbourne, Australia. She is Professor in the Department of Medicine, University of Melbourne and is an NHMRC Leadership fellow.

Prof. Slavin is immediate past- President of the International Immunocompromised Host Society and secretary of the Immunocompromised Host working group of ESCMID. Her research focuses on prevention, diagnosis and management of infections in the immunocompromised host with a particular interest in invasive fungal infection.

Michelle K. Yong

Michelle K. Yong

Dr Michelle K. Yong is an Infectious Diseases Physician and post-doctoral researcher at the University of Melbourne, Australia with clinical appointments at Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and the National Centre for Infections in Cancer (NCIC), University of Melbourne.

Her research focuses on cytomegalovirus (CMV) and viral infections in transplant and immune-compromised hosts, in particular, understanding CMV-related transplant outcomes and cytomegalovirus-specific immunity. Her PhD was undertaken at the Doherty Institute, Monash University, Melbourne, Australia, and Hopital Pitie-Salpetriere, Paris.

Dr Yong currently holds several highly competitive National Health and Medical Research Council investigator grant and Medical Research Future Fund grants investigating interventions for COVID-19 and CMV in the immune-compromised cancer population. She was a pivotal member in the organizing committee of the recent 2021 International Immunocompromised Host Society Symposium, hosted in Melbourne. Dr Yong currently sits on numerous national and international guideline writing panels in the management of CMV and fungal infections in the immune-compromised host. She also co-leads and is actively involved in clinical trials exploring novel viral and fungal therapeutics.

Matteo Bassetti

Matteo Bassetti

Matteo Bassetti is Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. Dr Bassetti studied at the University of Genoa School of Medicine and continued his medical education at the Yale University School of Medicine, New Haven, USA with an Infectious Diseases fellowship.

Dr Bassetti is Chair of the Critically Ill Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). He is member-elected (2018-2022) of International Council of the Immunocompromised Host Society (ICHS). From 2019 he is member of the council of International Sepsis Forum (ISF). He serves on the editorial board of several prestigious international journals. Author or co-author of 750 papers (H index 85; 30000 citations) published in international peer-review journals and several chapters in book on antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.